[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cataract-surgery\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cataract-surgery":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,15,0,[8,54,81,112,137,168,192,218,237,259,284,317,337,364,393],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":32,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100610448","effect-of-vision-centers-on-access-to-eye-care-and-eye-health-outcomes-100610448",false,"NCT07227714","Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes","A Cluster-Randomized Trial Evaluating the Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes in South Asia","Inclusion Criteria:\n\n* The catchment area of the proposed VC site is predominantly rural.\n* The proposed VC site is located within 20-100 km of the base hospital.\n* There are no major primary eye care services within 10 km of the proposed site.\n* Care at sites randomized to establish VCs immediately is accessible to anyone.\n\nExclusion Criteria:\n\n* Sites located in non-rural or urban catchment areas.\n* Sites outside the 20-100 km distance range from the base hospital.\n* Sites with existing major primary eye care services within a 10 km radius.",true,"ALL",{"count":19,"type":20},150000,"ESTIMATED","INTERVENTIONAL",[23],"NA","This cluster-randomized trial aims to evaluate the effect of vision centers on access to eye care and eye health outcomes in South Asia. The main questions it aims to answer are:\n\n1. Do vision centers improve effective refractive error coverage?\n2. Do vision centers increase eye care center utilization?\n3. Do vision centers improve population visual acuity?\n\nResearchers will compare outcomes in communities randomized to immediate versus delayed establishment of a vision center. Outcomes will be assessed through population-based surveys at baseline and after two years as well as through hospital records collected throughout the study period.",[26,27,28,29,30,31],"Cataract Surgery","Eye Care","Glasses","Primary Eye Care","Vision Center","Eyecare Visits",[33,34,35,36,37,38,39,40],"vision center","primary eye care","cataract surgery","glasses","glassess ownership","spectacle ownership","cluster-randomized trial","eyecare visits","NOT_YET_RECRUITING","2026-06-26",{"date":44,"type":45},"2026-06-30","ACTUAL",{"date":47,"type":20},"2026-08-01",{"date":49,"type":20},"2028-12-01",{"name":51,"class":52},"University of California, San Francisco","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":4,"eligibilityCriteria":60,"healthyVolunteers":11,"sex":17,"minAge":61,"maxAge":4,"enrollmentInfo":62,"targetDuration":4,"studyType":21,"phases":64,"briefSummary":65,"conditions":66,"keywords":67,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":53},"100630206","reducing-patient-waiting-time-for-cataract-surgery-100630206","NCT07484659","Reducing Patient Waiting Time for Cataract Surgery","Reducing Patient Waiting Time for Cataract Surgery Through Improved Coordination Between Ward and Operation Theatre","Inclusion Criteria:\n\n* Age \\> 20 years\n* Adult cataract surgical patients.\n\nExclusion Criteria:\n\n\\- Age \\\u003C 20 years","20 Years",{"count":63,"type":20},360,[23],"The purpose of this study is to examine how coordination between hospital departments affects patient flow between the free ward (B1), paid ward (C1) and the operating theatre (OT) for cataract surgeries at a tertiary eye care hospital. This will be an Interventional study using both quantitative and qualitative methods conducted at Tejas Eye Hospital.\n\nPatients aged 40-85 years, scheduled for cataract surgery during the study period will be included. Two trained investigators would observe the process and collect the data in structured format from ward admission to transfer into the operating theatre. Every participant would be observed from the ward on the day of his schedule surgery till his surgery is over in operation theatre. Demographic details and personal characteristics of every participant would be recorded in data collection form. In this pathway, timings, events, errors, deviations would be recorded at different spots between ward and operation theatre in first phase of study. Data would be collected from total 364 participants selected using stratified sampling technique.\n\nThe data will be analyzed using MS excel and EpInfo. Summary statistics would be calculated for different variables and listing of various events and errors would be done. Using the above analysis various delays, communication gaps and different deviation would be identified. A dissemination meeting would be organized with all involved in above processes and findings would be shared in detail. Specific intervention would be decided for execution in the second phase of this study.\n\nIn second phase, predetermined interventions from analysis of first phase would be implemented and similar data collection would be carried out to see the impact of interventions. Data collection would be done from the phase one sample size and comparison would be carried out for important variables like delays to establish the final outcome of the study. Similarly reduction in frequencies of errors and deviations would also be calculated.",[26],[68,69,70],"Waiting time","Operational errors","Eye care","RECRUITING","2026-04-29",{"date":74,"type":45},"2026-04-30",{"date":76,"type":45},"2026-03-01",{"date":78,"type":20},"2026-11",{"name":80,"class":52},"Seva Canada Society",{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":4,"eligibilityCriteria":87,"healthyVolunteers":16,"sex":17,"minAge":88,"maxAge":89,"enrollmentInfo":90,"targetDuration":4,"studyType":21,"phases":92,"briefSummary":93,"conditions":94,"keywords":99,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":53},"100579601","anxiety-and-surgery-satisfaction-for-cataract-patient-with-different-state-anxiety-100579601","NCT06826417","Anxiety and Surgery Satisfaction for Cataract Patient With Different State Anxiety","Pain, Anxiety and Anesthetic Satisfaction for Patient With Different State Anxiety Underwent Cataract Surgery With Topical Anesthesia","Inclusion Criteria:\n\n1. Age between 18 and 80 years old.\n2. Patients diagnosed with cataracts.\n3. Scheduled for cataract surgery with phacoemulsification and intraocular lens implantation under surface anesthesia at National Taiwan University Hospital.\n4. No adverse reactions to oral anti-anxiety medication (XANAX).\n\nExclusion Criteria:\n\n1. Presence of any contraindications for surgery before the procedure.\n2. Presence of any contraindications for medication before the procedure.\n3. Inability to provide clear and complete answers to relevant questionnaires, or expression of no preoperative anxiety during the outpatient visit, or scores below 21 on the STAI-S or STAI-T assessment.\n4. Regular use of anti-anxiety medications, sleeping pills, or analgesics before the procedure.\n5. Pregnancy or breastfeeding during the preoperative period.\n6. Severe corneal diseases, overripe cataracts, small pupils, or lens dislocation leading to difficulties in conventional surgery.\n7. Patients under surface anesthesia who cannot fully cooperate with the surgical procedure.\n8. Pregnant or uncertain pregnancy status (women under 55 years old to be verbally asked by research team members).","18 Years","80 Years",{"count":91,"type":20},400,[23],"This study aims to explore the effects of anxiety traits on pain, anxiety, and anesthesia satisfaction in patients undergoing cataract surgery under topical anesthesia. On the day of recruitment, patients will complete the BAI, STAI-S, and STAI-T anxiety questionnaires to assess baseline anxiety levels. Thirty minutes before the surgery, patients will be randomly assigned, in a double-blind manner, to receive either Xanax or a placebo and will retake the BAI, STAI-S, and STAI-T questionnaires. After the surgery, patients' pain levels and anesthesia satisfaction will be evaluated, with the pain scale and satisfaction survey repeated the following day. The results will analyze the relationship between anxiety traits and pharmacological interventions on the surgical experience, aiming to optimize surgical procedures and improve overall patient comfort.",[95,96,26,97,98],"Oral Anxiolytic","Phacoemulsification","Satisfaction Survey","State Anxiety",[100,96,101,102,98],"Oral anxiolytic","Cataract surgery","Satisfaction survey","2026-04-21",{"date":105,"type":45},"2026-04-23",{"date":107,"type":45},"2024-01-02",{"date":109,"type":20},"2026-12-31",{"name":111,"class":52},"National Taiwan University Hospital",{"id":113,"slug":114,"hasResults":11,"nctId":115,"briefTitle":116,"officialTitle":116,"acronym":4,"eligibilityCriteria":117,"healthyVolunteers":11,"sex":17,"minAge":88,"maxAge":4,"enrollmentInfo":118,"targetDuration":4,"studyType":120,"phases":4,"briefSummary":121,"conditions":122,"keywords":125,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":128,"lastUpdatePostDateStruct":129,"startDateStruct":131,"completionDateStruct":133,"leadSponsor":135,"locationsCount":53},"100629962","outcomes-of-cataract--refractive-procedures-100629962","NCT07481487","Outcomes of Cataract & Refractive Procedures","Inclusion Criteria:\n\n* Adult patients who have undergone a refractive procedure\n* Adult patients who have undergone a cataract procedure with implantation of an intraocular lens\n* Age ≥ 18 years old\n* Patient able to consent for their pseudonymised data to be used for research purposes\n\nExclusion Criteria:\n\n* NONE",{"count":119,"type":20},150,"OBSERVATIONAL","The primary objective of the database is to retrospectively analyse the visual and refractive outcomes of cataract and refractive procedures in order to continuously assess outcomes and also compare outcomes between the different IOLs, or the different refractive procedures.",[123,124,26],"Visual Correction","Refractive Surgery",[126,127],"cataract","IOL","2026-03-13",{"date":130,"type":45},"2026-03-18",{"date":132,"type":45},"2025-04-15",{"date":134,"type":20},"2026-10-31",{"name":136,"class":52},"Vision Care Collective Limited",{"id":138,"slug":139,"hasResults":11,"nctId":140,"briefTitle":141,"officialTitle":142,"acronym":143,"eligibilityCriteria":144,"healthyVolunteers":11,"sex":17,"minAge":88,"maxAge":4,"enrollmentInfo":145,"targetDuration":4,"studyType":21,"phases":147,"briefSummary":148,"conditions":149,"keywords":154,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":159,"lastUpdatePostDateStruct":160,"startDateStruct":162,"completionDateStruct":164,"leadSponsor":166,"locationsCount":53},"100627756","stress-ball-use-during-cataract-surgery-effects-on-pain-fear-and-satisfaction-100627756","NCT07452770","Stress Ball Use During Cataract Surgery: Effects on Pain, Fear and Satisfaction","The Effect of Stress Ball Use on Patients' Pain, Fear and Satisfication\" During Cataract Surgery","SBUDCS","Inclusion Criteria:\n\n* Individuals aged 18 years or older,\n* Without hearing or cognitive impairments,\n* Without any neurological conditions that would prevent squeezing a stress ball,\n* Without any physical limitations in the hands or arms that would prevent squeezing a stress ball,\n* Individuals undergoing cataract surgery for the first time will be included.\n\nExclusion Criteria:\n\n* Under 18 years of age,\n* Change in anesthesia type during surgery (from topical anesthesia to general anesthesia)\n* Patients scheduled for cataract surgery under general anesthesia,\n* Patients with psychiatric disorders,\n* Patients diagnosed with uncontrolled hypertension,\n* Patients who used any analgesic or anxiolytic prior to surgery will not be included in the study.",{"count":146,"type":20},60,[23],"The aim of this study is to determine the effect of stress ball use during cataract surgery on patients' pain, fear, and satisfaction levels.",[150,151,152,153,26],"Pain","Fear","Stress Ball","Nursing",[155,156,157,35,158],"pain management","Surgical fear","nursing","satisfaction","2026-03-05",{"date":161,"type":45},"2026-03-06",{"date":163,"type":45},"2025-09-01",{"date":165,"type":20},"2026-05-15",{"name":167,"class":52},"Bezmialem Vakif University",{"id":169,"slug":170,"hasResults":11,"nctId":171,"briefTitle":172,"officialTitle":173,"acronym":4,"eligibilityCriteria":174,"healthyVolunteers":11,"sex":17,"minAge":88,"maxAge":175,"enrollmentInfo":176,"targetDuration":4,"studyType":21,"phases":178,"briefSummary":179,"conditions":180,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":182,"lastUpdatePostDateStruct":183,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":4},"100625107","efficacy-of-epd-09-25-for-eyelid-hygiene-before-and-after-eye-surgery-100625107","NCT07418333","Efficacy of EPD-09-25 for Eyelid Hygiene Before and After Eye Surgery.","Open-label, Randomized, Two-arms Interventional Clinical Trial to Evaluate the Importance of the Cleansing Action of EPD-09-25 Before and After Eye Surgery","Inclusion Criteria:\n\n1. Male and female adults aged ≥ 18 and ≤ 85 years.\n2. Clinical diagnosis of cataract scheduled for cataract surgery.\n3. Provision of written informed consent as approved by the Ethics Committee (EC).\n\nExclusion Criteria:\n\n1. Patients with DED and MGD, before cataract surgery, confirmed at Visit 0 (screening and baseline). At least one of the following conditions (in the eye subjected to cataract surgery) must be met:\n\n   * TBUT \\\u003C 10s\n   * SPEED score \\> 4\n2. Recent (≤8 weeks) use or dose adjustment of systemic medications known to affect tear film or lacrimal section systemic antihistamines, antidepressant such as SSRI\u002FSNRI\u002FTCA, antiparkinsonian agents, anticholinergics, oral isotretinoin.\n3. Active or uncontrolled ocular allergy (e.g. allergic conjunctivitis, keratoconjunctivitis) within 4 weeks prior to screening or requiring therapy during the study.\n4. Ongoing ocular or systemic infectious (bacterial, viral or fungal) or suspected infection at screening.\n5. Recurrent bacterial conjunctivitis (at least once a month in the last 6 months)\n6. Any intraocular surgery within 12 months prior to screening or planned intraocular surgery during the study (other than the cataract procedure under study).\n7. Acute (active at the screening and baseline visit) or Chronic (persistent) Conjunctival Disease (e.g., symptomatic pterygium, cicatricial conjunctivitis); conditions that may alter the ocular surface and influence the assessment of symptoms.\n8. Eyelid surgery within the 6 months prior to study enrolment.\n9. Congenital absence (genetic defect) of lacrimal or Meibomian glands or clinically significant obstruction of the lacrimal glands (blockage of the tear drainage system (e.g. nasolacrimal duct stenosis) which can cause excessive tearing or alter the distribution of the tear film.\n10. History of ocular herpetic keratitis or active blepharitis, demodex infestation or ocular rosacea within 4 weeks prior to study enrolment.\n11. History of autoimmune diseases requiring systemic immunosuppressive therapy.\n12. Clinically significant eyelid malposition or mechanical abnormalities, in accordance with PI's clinical judgment.\n13. History of corneal diseases (e.g., keratoconus, keratitis, keratoconjunctivitis, corneal dystrophies, permanent damage due to corneal ulcer)\n14. History of corneal transplant in one or both eyes\n15. Keratinization of the eyelid margin\n16. History of Sjögren's syndrome\n17. History of corneal trauma within 4 weeks prior to study enrolment.\n18. Inability to self-administer study device or absence of a caregiver able to assist with administration medication.\n19. Women of childbearing potential who are pregnant, breastfeeding, planning to become pregnant during the study, or not using adequate birth control methods to prevent pregnancy throughout the study.\n20. Known hypersensitivity to any of the investigational device components (e.g. PQ-133, Gombo, Kolliphor, etc) or wipes materials.\n21. Legally or mentally incapacitated participants are unable to provide written informed consent.\n22. Participants are unable or unwilling to comply with scheduled visits, procedures, or protocol requirements.\n23. Chronic use of topical ocular hypotensive medications (e.g., for glaucoma).\n24. Patients undergoing intravitreal injections.\n25. Recent use (≤4 weeks) of topical or systemic therapies for DED\u002FMGD that could confound efficacy outcomes, including cyclosporine, lifitegrast, prolonged topical corticosteroids, autologous serum, or procedural treatments such as IPL, LipiFlow, or similar interventions within the past 3-6 months, or punctal plugs placed within 3 months.\n26. Use of contact lenses within 2 weeks prior to screening or planned use during the study.","85 Years",{"count":177,"type":20},100,[23],"This is an interventional, open-label, two-arms clinical trial, randomized 1:1 (EPD treatment or no eyelid hygiene treatment) in patients scheduled for eye surgery (cataract surgery). The purpose of the study is to evaluate the importance of the cleansing action of EPD-09-25 before and after eye surgery.",[26,181],"Ocular Infections","2026-02-18",{"date":184,"type":45},"2026-02-20",{"date":186,"type":20},"2026-04-01",{"date":188,"type":20},"2026-11-01",{"name":190,"class":191},"VISUfarma SpA","INDUSTRY",{"id":193,"slug":194,"hasResults":11,"nctId":195,"briefTitle":196,"officialTitle":197,"acronym":4,"eligibilityCriteria":198,"healthyVolunteers":11,"sex":17,"minAge":88,"maxAge":4,"enrollmentInfo":199,"targetDuration":4,"studyType":21,"phases":201,"briefSummary":202,"conditions":203,"keywords":204,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":209,"lastUpdatePostDateStruct":210,"startDateStruct":212,"completionDateStruct":214,"leadSponsor":216,"locationsCount":53},"100601261","the-effect-of-hand-holding-and-stress-ball-intervention-on-pain-and-anxiety-100601261","NCT07108192","The Effect of Hand Holding and Stress Ball Intervention on Pain and Anxiety","The Effect of Hand Holding and Stress Ball Intervention on Pain and Anxiety During Cataract Surgery: A Randomized Controlled Trial","Inclusion Criteria:\n\n* 18 years and over\n* Can understand and speak Turkish\n* Clear consciousness, person, place and time oriented\n* No hearing and perception problems\n* Does not have any mental or neurological disorders that may affect communication (Alzheimer's, dementia, etc.)\n* First time cataract surgery\n* Those without any psychiatric diagnosis\u002F treatment (antidepressants, anxiolytics, sedatives, etc.)\n* No physical problems in squeezing the stress ball (muscle, joint problems, etc.)\n* No analgesic or anesthetic medication 24 hours before the procedure\n* Individuals who agree to participate in the study will be included in the study\n\nExclusion Criteria:\n\n* Conversion of topical anesthesia to general anesthesia during surgery\n* A different story of eye surgery\n* Hearing, speech, physical or mental disability\n* Pregnancy or possible pregnancy\n* Those with malignancy\n* Taking an analgesic medication at least 24 hours before the procedure\n* People with chronic pain\n* History of incomplete or canceled cataract procedures\n* Hypertension in the patient (\\>160\u002F100 mmHg)\n* Suppurative\u002Finfective\u002Finflammatory skin condition of the hands\n* Hypersensitivity to touch\n* Patients with contact-transmitted diseases\n* Being uncomfortable with hand-holding,\n* In case of need for emergency intervention by a physician during or immediately after the procedure\n* Failure to perform the stress ball application in accordance with the instruction\n* Pre-existing neuropathy (muscle joint problem, stroke, etc.)\n* Complications during cataract surgery\n* Those who want to leave the study voluntarily\n* Termination of the procedure due to deterioration of the patient's general condition during the procedure\n* Failure to carry out intervention practices in accordance with the determined protocol (Dropping the stress ball during the procedure, etc.)",{"count":200,"type":20},108,[23],"Cataract surgery is currently primarily performed with topical anesthesia. Although topical anesthesia provides many benefits for patients, they may experience pain, anxiety and discomfort during surgery. It has been reported that increased pain and anxiety during surgery may decrease patient cooperation and satisfaction, making surgery more difficult. In this context, in addition to medical interventions, non-pharmacologic methods are recommended to manage pain and anxiety during surgery. Non-pharmacological methods are reported to be simple, effective and cost-effective. In this context, studies have shown that stress ball application and hand holding are effective strategies for the control of pain and anxiety in patients.\n\nAccording to this information, the aim of this study was to evaluate the effect of stress ball application and hand holding method used during cataract surgery on patients' pain and anxiety.\n\nAnother aim of the study was to determine the effects of stress ball application and hand holding method on patients' satisfaction levels and vital signs.",[26],[205,206,207,208,35],"hand holding","stress ball","pain","anxiety","2026-02-04",{"date":211,"type":45},"2026-02-06",{"date":213,"type":45},"2025-10-08",{"date":215,"type":20},"2026-07-01",{"name":217,"class":52},"Sakarya University",{"id":219,"slug":220,"hasResults":11,"nctId":221,"briefTitle":222,"officialTitle":222,"acronym":223,"eligibilityCriteria":224,"healthyVolunteers":11,"sex":17,"minAge":88,"maxAge":4,"enrollmentInfo":225,"targetDuration":4,"studyType":120,"phases":4,"briefSummary":227,"conditions":228,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":229,"lastUpdatePostDateStruct":230,"startDateStruct":232,"completionDateStruct":233,"leadSponsor":235,"locationsCount":53},"100620778","assessment-of-a-hand-held-femtosecond-laser-to-perform-anterior-capsulorhexis-during-cataract-surgery-post-market-study-100620778","NCT07362043","Assessment of a Hand-held Femtosecond Laser to Perform Anterior Capsulorhexis During Cataract Surgery (Post-market Study)","PMCF_SEQ_Rx","Inclusion Criteria:\n\n* Adult patients (age \\> 18 years);\n* Diagnosed with cataract requiring surgery according to current guidelines;\n* Eligible to lens removal by phacoemulsification and replacement by a prosthetic lens under local anesthesia;\n* Who confirmed their non-opposition to data collection\n\nExclusion Criteria:\n\n* Patient already operated with Rx for the first eye.\n* Any contra-indication to cataract surgery;\n* Patients with an ACD (Anterior Chamber Depth) less than 1.8mm and greater than 4.2mm;\n* Corneal disease or pathology that prevents corneal applanation or that may interfere with or hinder laser beam transmission;\n* Presence of blood or any other element that hinders the propagation of light between the epithelium and the anterior surface of the lens where the capsulotomy will be performed;\n* Weak pupil dilation or severely off-center pupil that prevents the iris from retracting adequately to the periphery (dilations \\\u003C 6.5mm in diameter are excluded);\n* Abnormal tilt of the lens (\\> 7 degrees) ;\n* Significant preoperative ocular hypotonia or hypertonia;\n* Presence of an intra-corneal implant;\n* Active or unstabilized ocular surface disease including abnormal corneas (e.g., epithelial dystrophies,recurrent ulcers, infectious foci, conjunctivitis, severe dry syndromes);\n* History of lens disease or zonular instability;\n* Any perforating incision of the eyeball that may result in leakage during corneal applanation;\n* Presence of a limbal tumor obstacle that may interfere with stabilization of the device on the limbus: pterygium, limbal tumor, filter bubble, etc.\n* Patients under guardianship, trusteeship or deprived of liberty;\n* Patients unable to give their non-opposition for data collection for psychiatric, cognitive or linguistic reasons.",{"count":226,"type":20},446,"The goal of this observationnal study is to supplement the data collected in the pre-market study and confirm the rate of capsular ruptures due to Rx (reducing its related confidence interval).\n\nDuring cataract surgery, an artificial lens is placed into the capsular bag. The main question this study aims to answer is :\n\nIs Rx use associated with a rate of caspular ruptures lower than 2% ? Medical records of participants having cataract surgery with Rx laser as part of their regular medical care will be assessed in order to answer the study objective.",[26],"2026-01-28",{"date":231,"type":45},"2026-01-30",{"date":229,"type":45},{"date":234,"type":20},"2028-03",{"name":236,"class":191},"Helix Surgical",{"id":238,"slug":239,"hasResults":11,"nctId":240,"briefTitle":241,"officialTitle":242,"acronym":243,"eligibilityCriteria":244,"healthyVolunteers":11,"sex":17,"minAge":88,"maxAge":4,"enrollmentInfo":245,"targetDuration":4,"studyType":21,"phases":247,"briefSummary":248,"conditions":249,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":250,"lastUpdatePostDateStruct":251,"startDateStruct":253,"completionDateStruct":255,"leadSponsor":257,"locationsCount":4},"100614431","clinical-investigation-of-ixium-twin-viscoelastic-ophthalmic-device-for-cataract-surgery-100614431","NCT07279506","Clinical Investigation of IXIUM TWIN Viscoelastic Ophthalmic Device For Cataract Surgery","Randomized Clinical Investigation Of The IXIUM TWIN Viscoelastic Ophthalmic Device (OVD) For Cataract Surgery With Intraocular Lens Implantation","IXIUM_TWIN","Inclusion Criteria:\n\n* Adult patients (≥18 years) with cataract (described and coded per WHO classification²⁷)\n* One eye per patient enrolled in the clinical investigation (IC)\n* Intraocular pressure (IOP) controlled or uncontrolled with treatment\n* Cataract extraction via phacoemulsification with implantation of a posterior chamber injectable intraocular lens (IOL) through a small incision\n* Signed informed consent from both patient and physician\n* Patient capable of understanding the IC procedures and geographically stable\n* Patient covered by or eligible for a social security\u002Fhealth insurance system\n\nExclusion Criteria:\n\n* Patient unable to participate in a clinical investigation (IC)\n* Pregnant women or those at risk of pregnancy during the study\n* Patient under legal guardianship (tutelle), conservatorship (curatelle), or judicial protection (sauvegarde de justice)\n* Patient currently enrolled in another clinical investigation at the time of inclusion",{"count":246,"type":20},180,[23],"This clinical trial is testing a new surgical gel called IXIUM TWIN, designed to protect the eye during cataract surgery. Cataracts, which cloud the eye's natural lens, are the leading cause of vision loss worldwide. Surgery to remove the cataract and replace it with an artificial lens is the standard treatment, and viscoelastic gels like IXIUM TWIN are used to keep the eye stable and safe during the procedure.\n\nThe goal of this study is to compare IXIUM TWIN with an already approved gel (HEALON) to ensure it works just as well (or better) in protecting the delicate cells inside the eye. Specifically, researchers will measure whether IXIUM TWIN causes less damage to the eye's inner lining (endothelial cells) after surgery.\n\nWho can take part? Adults aged 18 and older who have cataracts and are scheduled for surgery may qualify. Only one eye per participant will be included. Patients must be able to attend follow-up visits and provide informed consent.\n\nWhat does participation involve? Before surgery, participants will have eye exams to check vision, cell health, corneal thickness, and eye pressure. During surgery, they will randomly receive either IXIUM TWIN or HEALON (neither the patient nor the surgeon will choose). After surgery, follow-up visits at 1 day, 7 days, 30 days, and 90 days will monitor healing, vision improvement, and any side effects.\n\nPotential risks and benefits As with any cataract surgery, there are minor risks, such as temporary increased eye pressure, inflammation, or swelling, but these are rare and usually resolve quickly. The benefits include improved vision after cataract removal. If successful, IXIUM TWIN could offer surgeons another high-quality option for protecting the eye during surgery.\n\nStudy timeline Patient enrollment begins in January 2025 and ends in June 2025, with follow-ups completing by September 2025. The full study is expected to conclude in early 2026.\n\nThis study is sponsored by LCA Pharmaceutical and will take place at four hospitals in France. Participation is voluntary, and patients can withdraw at any time.",[26],"2025-12-09",{"date":252,"type":45},"2025-12-12",{"date":254,"type":20},"2026-01",{"date":256,"type":20},"2026-09",{"name":258,"class":191},"LCA Pharmaceutical",{"id":260,"slug":261,"hasResults":11,"nctId":262,"briefTitle":263,"officialTitle":263,"acronym":264,"eligibilityCriteria":265,"healthyVolunteers":11,"sex":17,"minAge":88,"maxAge":4,"enrollmentInfo":266,"targetDuration":4,"studyType":21,"phases":267,"briefSummary":268,"conditions":269,"keywords":272,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":275,"lastUpdatePostDateStruct":276,"startDateStruct":278,"completionDateStruct":280,"leadSponsor":282,"locationsCount":53},"100606675","comparing-efficacy-of-bromfenac-009-nepafenac-03-and-diclofenac-01-in-patients-after-cataract-surgery-100606675","NCT07178639","Comparing Efficacy of Bromfenac 0.09%, Nepafenac 0.3% and Diclofenac 0.1% in Patients After Cataract Surgery","BND","Inclusion Criteria:\n\n* Are male or female at least 18 years of age who require cataract surgery and no other surgical procedures during the cataract surgery.\n* Agree not to have any other ocular surgical procedures in the study or fellow (non study) eye within 15 days prior to the initiation of dosing with the test article or throughout the duration of the study.\n* Have a Best Corrected Visual Acuity of 20\u002F200 or better in either eye.\n* Are able to self administer test article (or have a caregiver available to instill all doses of test article).\n\nExclusion Criteria:\n\n* Have known hypersensitivity to bromfenac, nepafenac, diclofenac or any component of the test article (including \"procedural\" medications such as anesthetic and\u002For fluorescein drops, dilating drops, etc.).\n* Have intraocular inflammation (i.e., cells or flare in the anterior chamber as measured on slit lamp examination) in study eye at screening visit.\n* Have a known blood dyscrasia or bone marrow suppression, a diagnosis of uncontrolled\u002Funstable peptic ulcer disease, inflammatory bowel disease, or ulcerative colitis, or any uncontrolled\u002Funstable pulmonary, cardiac, vascular, autoimmune, hepatic, renal, or central nervous system disease.\n* Have used ocular, topical, or systemic NSAIDs or ocular, topical, or systemic gentamicin, or cyclosporine ophthalmic emulsion within 7 days prior to initiation of dosing with the test article or throughout the duration of study,with exception of allowing patients on a stable dose of aspirin 81 mg daily or less.\n* Have diabetes of any type.\n* Have any pathology of vitreoretinal interface (recognised on opcital coherence tomography).\n* Have any history of pars plana vitrectomy in the study eye.\n* Have glaucoma of the following types: any secondary, closed angle, severe open angle.\n* Have used ocular prostaglandins within 30 days prior to initiation of dosing with test article or throughout the duration of study.\n* Have active corneal pathology noted in the study eye at screening visit. Active corneal pathology is defined as corneal pathology that is non stable, or greater than mild, or will compromise assessment of the safety or efficacy of treatment. Superficial punctate keratitis in study eye.\n* Have any extraocular\u002Fintraocular inflammation in the study eye at screening visit (blepharitis allowed if mild only, and no concurrent conjunctivitis or lid erythema\u002Fedema) or ongoing, unresolved uveitis.\n* Have used topical, ocular, inhaled or systemic steroids within 14 days prior to screening.\n* Have a history of abuse of alcohol\u002Fdrugs within six months prior to the screening visit.\n* Are pregnant or nursing\u002Flactating.\n* Have participated in any other study of an investigational drug or device within 30 days prior to randomization.",{"count":119,"type":20},[23],"The goal of this clinical trial is to learn which of the drugs bromfenac 0.09%, nepafenac 0.3% and diclofenac 0.1% has better efficacy in treatment and prevention of cystoid macular oedema after cataract surgery.\n\nThe main questions it aims to answer are:\n\nWhich of the drugs has better efficacy in macular oedema prevention? What medical problems do participants have when taking different drugs? Researchers will compare drugs to each other.\n\nParticipants will:\n\nTake on of the drugs (randomized) as their treatment in preoperative and postoperative period.\n\nVisit the clinic after the surgery on the first day, first week, in three weeks and in six weeks.\n\nUndergo retina examination with OCT (optical coherence tomography), best vision, and fill in forms considering their quality of life.",[270,26,271],"Macular Oedema","NSAID (Non-Steroidal Anti-Inflammatory Drug)",[273,35,274],"macular oedema","macular oedema treatment","2025-09-10",{"date":277,"type":45},"2025-09-17",{"date":279,"type":45},"2025-08-01",{"date":281,"type":20},"2026-02-28",{"name":283,"class":52},"Nemocnice Kolín",{"id":285,"slug":286,"hasResults":11,"nctId":287,"briefTitle":288,"officialTitle":289,"acronym":290,"eligibilityCriteria":291,"healthyVolunteers":11,"sex":17,"minAge":292,"maxAge":4,"enrollmentInfo":293,"targetDuration":4,"studyType":21,"phases":294,"briefSummary":295,"conditions":296,"keywords":298,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":309,"lastUpdatePostDateStruct":310,"startDateStruct":312,"completionDateStruct":314,"leadSponsor":315,"locationsCount":53},"100597171","low-level-light-therapy-versus-intense-pulsed-light-to-prevent-iatrogenic-dry-eye-disease-after-cataract-surgery-100597171","NCT07055022","Low-level Light Therapy Versus Intense Pulsed Light to Prevent Iatrogenic Dry Eye Disease After Cataract Surgery","Low-level Light Therapy Versus Intense Pulsed Light to Prevent Iatrogenic Dry Eye Disease After Cataract Surgery: a Randomised Controlled Trial","EDACS","Inclusion Criteria:\n\n* aged ≥50 years\n* scheduled for bilateral cataract surgery by phacoemulsification\n* without current DED treatment, including eye drops, for at least two months before the inclusion\n* with preoperative OSDI ≤22 points, indicating absence of DED or mild DED\n* who signed the informed consent and are willing to comply with the protocol requirements based on the investigator's judgment\n* affiliated with a social security scheme\n* with an ability to answer questionnaires and to communicate freely in French.\n\nExclusion Criteria:\n\n* set to undergo implantation of a multifocal intraocular lens\n* using contact lenses\n* with any of the following in the included eye: (i) age-related macular degeneration (AMD), (ii) previous ocular surgery, (iii) abnormal clinical exam of the ocular surface or (iv) undergoing any ocular treatment\n* with systemic contraindications, including autoimmune diseases (e.g., Sjögren syndrome)\n* with general contraindications for LLLT or IPL treatment: dark pigmented skin (Fitzpatrick grade ≥5), skin photosensitivity (regardless if innate, pathological or medically-induced), or neurological light sensitivity (e.g. epilepsy, light-induced migraines)\n* with contraindications for LLLT or IPL treatment limited to the treatment area: history of skin cancer, skin pigmented lesions, as well as fixed\u002Fpermanent skin piercings, face tattoos, semi-permanent make-up (including microblading) or skin defects\n* with any concomitant disease or disorder which, in the opinion of the investigator, may put the patient at risk or may influence the result of the study\n* with protected status under articles L1121-6, LL121-8 and L1122-2 of the French Public Health Code\n* who cannot comply with the protocol requirements based on the investigator's judgment.","50 Years",{"count":146,"type":20},[23],"Dry eye disease (DED) is a frequent ocular surface disease (OSD) of multifactorial origin, characterised by disruption of tear film homeostasis and associated with ocular discomfort and\u002For visual disturbance. Cataract surgery, which is one of the most often performed interventions worldwide, can induce or worsen the symptoms of DED. Despite lack of guidelines on DED prophylaxis before cataract surgery in the general population, there is a growing interest in this topic due to the high prevalence of postoperative DED. A recent randomised controlled trial (RCT) with one month follow-up showed that prophylactic low-level light therapy (LLLT) before and after cataract surgery in patients without pre-existing DED significantly improved postoperative tear film stability, as well as reduced ocular discomfort, compared to no prophylaxis. Apart from LLLT, another light-based treatment for DED is intense pulsed light (IPL); the treatments have shown favourable outcomes in the management of DED, both as stand-alone choices or in combination.",[26,297],"Eye Dryness",[299,300,301,302,35,303,304,305,306,307,308],"IPL","LLLT","Intense Pulse Light","Low Level Light Therapy","phacoemulsification","prophylaxis","prevention","eye dryness","dry eye disease","DED","2025-07-07",{"date":311,"type":45},"2025-07-08",{"date":313,"type":20},"2025-09-30",{"date":44,"type":20},{"name":316,"class":52},"Clinique Trenel",{"id":318,"slug":319,"hasResults":11,"nctId":320,"briefTitle":321,"officialTitle":321,"acronym":4,"eligibilityCriteria":322,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":323,"targetDuration":4,"studyType":120,"phases":4,"briefSummary":325,"conditions":326,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":328,"lastUpdatePostDateStruct":329,"startDateStruct":331,"completionDateStruct":333,"leadSponsor":335,"locationsCount":53},"100587173","clinical-outcomes-of-bilateral-clareon-vivity-in-post-refractive-patients-100587173","NCT06924944","Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients","Inclusion Criteria:\n\n* o Bilateral age-related visually significant cataracts in otherwise healthy eyes, undergoing uncomplicated bilateral sequential Clareon Vivity IOLs\n\n  * Prior history of uncomplicated post-refractive myopic surgery (LASIK\u002FPRK) with up to 1 enhancement treatment\n  * Potential acuity measured post-operatively 20\u002F25 or better in both eyes\n  * Patients with regular astigmatism that can be managed with T3 toric lens or arcuate incision\n\nExclusion Criteria:\n\n* o Ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity such as severe dry eye\u002Focular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, etc.\n\n  * Prior ocular surgeries other than uncomplicated corneal refractive surgery and excluding RK\n  * Patients with irregular astigmatism\u002Ftopography (to rule out signs of potential ectasia), corneal dystrophies, and pupil abnormalities\n  * Total HOA cutoff of ≤0.5, coma ≤0.3\n  * RLE patients",{"count":324,"type":20},35,"Millions of people have undergone laser vision correction surgery and are motivated to continue with spectacle independence as they develop presbyopia (gradual loss of your eyes' ability to focus on nearby objects)and cataract. However, having a history of refractive surgery, poses challenges in the selection of the IOLs and can lead to visual outcomes that are unpredictable. Data from an international registry and single prospective study show that Vivity IOL provided effective distance, intermediate and near vision in eyes with previous LASIK with minimal effects on day vision associated with the surgery. The purpose of this study is to evaluate the clinical outcomes of post-myopic refractive surgery patients implanted with the Clareon Vivity\u002FVivity Toric lenses",[327,26],"Correction Vision Surgery","2025-04-09",{"date":330,"type":45},"2025-04-13",{"date":332,"type":45},"2025-01-20",{"date":334,"type":20},"2026-04",{"name":336,"class":52},"Utah Eye Centers",{"id":338,"slug":339,"hasResults":11,"nctId":340,"briefTitle":341,"officialTitle":342,"acronym":4,"eligibilityCriteria":343,"healthyVolunteers":11,"sex":17,"minAge":344,"maxAge":4,"enrollmentInfo":345,"targetDuration":4,"studyType":21,"phases":347,"briefSummary":349,"conditions":350,"keywords":352,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":356,"lastUpdatePostDateStruct":357,"startDateStruct":359,"completionDateStruct":361,"leadSponsor":362,"locationsCount":53},"100514562","phase-4-remimazolam-for-cataract-surgery-100514562","NCT05980117","Remimazolam for Cataract Surgery","Comparison of Remimazolam vs. Midazolam for Sedation During Cataract Surgery","Inclusion Criteria:\n\n1. Adult patients age \\> 65 years undergoing first eye cataract surgery under local topical anesthesia at the University of California, Los Angeles (UCLA).\n2. Both male and female patients\n3. American Society of Anesthesiologists Class 2, 3, and 4.\n\nExclusion Criteria:\n\n1. Patients who are unable to consent for the study\n2. Patients who are unable to cooperate with the cognitive assessment such as patients with significant visual, auditory, language or other impairment.\n3. Patients who are unable to understand simple English commands.\n4. Patients who do not wish to have benzodiazepine medication during surgery\n5. Patients with a history of severe hypersensitivity reaction to dextran 40 or products containing dextran 40.\n6. Patients with chronic pain on opiates.\n7. Patients with a history of drug, alcohol abuse\u002Fdependence.\n8. Patients with BMI \\> 40.\n9. Patients with obstructive sleep apnea (moderate to severe).","65 Years",{"count":346,"type":20},120,[348],"PHASE4","The goal of this study is to assess any post operative cognitive changes following benzodiazepine administration during cataract surgery. The investigators will compare effects of Midazolam vs. Remimazolam on cognition at the time of discharge from the post operative care unit and the next day following surgery.\n\nCognitive changes will be assessed by administration of Montreal Cognitive Assessment (MoCA).\n\nParticipants will:\n\n1. Complete MoCA testing prior to surgery\n2. Randomize in either Midazolam or study drug Remimazolam\n3. Complete MoCA testing after surgery at the time of discharge in the post anesthesia care unit and the next day of surgery at the time of post operative surgical visit.\n4. Complete Patient Satisfaction Survey at the time of discharge from the Post Anesthesia Care Unit (PACU)",[26,351],"Cognitive Impairment",[353,354,355],"Midazolam","Remimazolam","Outcomes","2025-03-17",{"date":358,"type":45},"2025-03-19",{"date":360,"type":45},"2025-03-10",{"date":254,"type":20},{"name":363,"class":52},"University of California, Los Angeles",{"id":365,"slug":366,"hasResults":11,"nctId":367,"briefTitle":368,"officialTitle":369,"acronym":370,"eligibilityCriteria":371,"healthyVolunteers":11,"sex":17,"minAge":88,"maxAge":4,"enrollmentInfo":372,"targetDuration":4,"studyType":21,"phases":373,"briefSummary":374,"conditions":375,"keywords":377,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":383,"lastUpdatePostDateStruct":384,"startDateStruct":386,"completionDateStruct":388,"leadSponsor":390,"locationsCount":392},"100548797","trial-comparing-cataract-surgery-with-triple-dmek-in-patients-with-cataract-and-fuchs-endothelial-corneal-dystrophy-100548797","NCT06425666","Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy","European Prospective Multicentre Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy (ETCF-trial)","ETCF","Inclusion Criteria:\n\n1. Patients with FECD and nuclear cataract in study eye\n2. Male and female patients ≥18 years of age\n3. Subject must be able to understand and read the national language.\n4. Written informed consent prior to any study-related procedures\n5. Nuclear opalescence (NO) grades 2 and 3 according to the lens opacities classification system III (LOCS III)\n6. Krachmer grade (3 \\[2-5 mm diameter area with confluent guttae\\]; 4 \\[ \\> 5 mm diameter area with confluent guttae\\] without edema identified by slit lamp examination)\n7. Central corneal thickness (CCT) measured with Pentacam below 620 µm between 8:00 am and 01:00 pm\n8. BCVA logMAR \\\u003C 0,7 and \\> 0,1\n9. No previous cataract surgery or triple-DMEK on the opposite side\n10. Pentacam quality specification: \"OK\"\n11. For women below age of 60 negative urine pregnancy test\n\nExclusion Criteria:\n\n1. Patients with ocular and\u002For systemic comorbidity affecting vision or clinically proven anterior and\u002For posterior segment disease other than FECD and cataract (exclusion of macular disease or edema by OCT)\n2. Iris synechiae, pupil diameter \\\u003C6 mm after dilatation, pseudoexfoliation syndrome, subluxated lens, previous history of ocular trauma\u002Fsurgery or inflammatory disease\n3. Subjective diurnal changes in visual acuity with worse visual acuity in the morning\n4. Corneal (epithelial) edema visible at slit lamp examination\n5. Preoperative anterior chamber depth below 2 mm\n6. Participation in other interventional trials parallel or within the last 4 weeks\n7. Systemic use of Alpha-1-Adrenozeptor-Antagonists, immunosuppressive therapy or chemotherapy\n8. Pregnant women and nursing mothers\n9. Persons with any kind of dependency on the principal investigator or employed by the sponsor or principal investigator\n10. Legally incapacitated persons\n11. Persons held in an institution by legal or official order",{"count":346,"type":20},[23],"The purpose of the study is to investigate whether there is a difference in BCVA in patients who receive one of the following two surgeries: intervention group (arm 1) cataract surgery alone and control group (arm 2) cataract surgery combined with removal of the diseased endothelial cells and the attached Descemet's membrane followed by transplantation of a healthy endothelial cell layer with attached Descemet's membrane (\"triple-DMEK\" group; comparator therapy).\n\nThe secondary objectives are to compare the two surgical methods with regard to other visual functions and optical as well as morphological differences, to safety, to quality of life, and to safety.",[26,376],"Cataract and Fuchs Endothelial Corneal Dystrophy",[378,379,380,381,382],"Fuchs´ Endothelial Corneal Dystrophy Krachmer grade 3 and 4","nuclear cataract","Nuclear opalescence (NO) grades 2","Nuclear opalescence (NO) grades 3","Central corneal thickness","2025-02-19",{"date":385,"type":45},"2025-02-21",{"date":387,"type":45},"2025-01-24",{"date":389,"type":20},"2026-06",{"name":391,"class":52},"University of Cologne",4,{"id":394,"slug":395,"hasResults":11,"nctId":396,"briefTitle":397,"officialTitle":397,"acronym":4,"eligibilityCriteria":398,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":399,"targetDuration":4,"studyType":21,"phases":401,"briefSummary":402,"conditions":403,"keywords":407,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":409,"lastUpdatePostDateStruct":410,"startDateStruct":412,"completionDateStruct":413,"leadSponsor":415,"locationsCount":4},"100579263","virtual-reality-and-its-use-in-reducing-perioperative-stress-in-cataract-surgery-100579263","NCT06822023","Virtual Reality and Its Use in Reducing Perioperative Stress in Cataract Surgery","Inclusion Criteria:\n\n1. Patients listed for cataract surgery under local anaesthetic (topical or regional) with sedation planned.\n2. First eye cataract procedures will only be included.\n3. Capacity to give informed consent, cognitive and linguistic ability sufficient to understand and fill out questionnaire\n\nExclusion Criteria:\n\n1. Epilepsy\n2. severe vertigo\n3. poor visual acuity (below 6\u002F60 best corrected in the best seeing eye)\n4. significant hearing impairment\n5. recent facial injury\u002Fburn.",{"count":400,"type":20},75,[23],"This project is to evaluate the benefits of utilising virtual reality (VR) headsets with the aim of reducing peri-operative anxiety in cataract surgery and hence reducing the need for sedation in patients with significant stress levels noted during preassessment. This is a novel study, and with the increased use of VR technology throughout medicine, we may be able to offer our patients alternative management modalities to reduce stress and reduce need for medications with their subsequent potential side effects. It may also improve the quality of care provided and patients' experience with the cataract extraction procedure and might reduce the social care burden associated with standard sedation procedures. All patients will need to fill a quick preoperative anxiety and information scale questionnaire to assess their level of anxiety utilising The Amsterdam Preoperative Anxiety and Information Score.\n\nPatients will be randomised into 2 groups:\n\n1. Conventional group: patients will be prepared as per the standard routine clinical and further explanation of the procedure will be given. Before proceeding to the anaesthetic room, the patients will complete the anxiety score questionnaire again and given the option to proceed with sedation or opt out.\n2. Interventional Group: patients will be prepared as per the standard routine clinical care; they will then be wearing the VR mask for 10 minutes. Before proceeding to the anaesthetic room, patients will complete the anxiety score questionnaire again and given the option to proceed with sedation or opt out.\n\nPost operation, a record will be taken of the surgeon's decision on whether they want the second eye cataract surgery to be done under sedation (this is already standard practice at our centre). Finally, the patient will be asked to fill in one final grading score on whether they are happy with their decision to take\u002Fnot take sedation.",[404,405,406,26],"Virtual Reality","Eye Disease","Cataract Surgery Anesthesia",[408],"cataract surgery, sedation, anxiety, virtual reality","2025-02-06",{"date":411,"type":45},"2025-02-12",{"date":411,"type":20},{"date":414,"type":20},"2025-12-01",{"name":416,"class":52},"South Tyneside and Sunderland NHS Foundation Trust"]